R&D News | pharmaphorum

News

FDA sets out its thinking on protecting children in clinical...

The FDA has published draft guidance giving its position on the ethical reasons for including children in clinical trials, and protecting them from harm.

News

A sweet little mixed race boy sits up on an examination table as he receives an immunization. He is looking up and smiling as the doctor places the bandage on his arm. Both are wearing medical masks to protect them from COVID.

Pfizer/BioNTech ask FDA for EUA of Omicron bivalent vaccine ...

A submission to the US Food and Drug Administration (FDA) requesting an Emergency Use Authorization (EUA) of a 10-µg booster dose of Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine for

Views & Analysis

Lilly’s Mounjaro wins latest head-to-head battle in clinical...

Diabetes is one of the most common health conditions in the United States, afflicting more than 11% of the population, with over 90% included in the type 2 category.

News

Lava fires up a $700m cancer licensing deal with Seagen

While a rumoured takeover by Merck & Co has yet to materialise, Seagen is getting

News

Pfizer, Sangamo resume haemophilia gene therapy trial

Pfizer and Sangamo have restarted recruitment of patients into their registration trial for haemophilia A gene therapy giroctocogene fitelparvovec, after the FDA lifted a clinical hold on t

News

West Chester - Circa November 2020: AstraZeneca plant. AstraZeneca has been working on a vaccine for the Coronavirus, COVID and COVID-19.

AZ and Ionis' PCSK9 cholesterol drug will not move to phase ...

AstraZeneca has taken the decision not to move a PCSK9-targeting antisense drug licensed from Ionis into a phase 3 programme, removing a competitor to Novartis' rival therapy Leqvio.

FDA sets out its thinking on protecting children in clinical...

Pfizer/BioNTech ask FDA for EUA of Omicron bivalent vaccine ...

Lilly’s Mounjaro wins latest head-to-head battle in clinical...

Lava fires up a $700m cancer licensing deal with Seagen

Pfizer, Sangamo resume haemophilia gene therapy trial

AZ and Ionis' PCSK9 cholesterol drug will not move to phase ...

Moderna's Q1 revenues rocket, thanks to ex-US sales

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks